Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.
Bayer Cropscience financials and key ratios
Figures from the company's filings with NSE
In FY26 its consolidated net profit was ₹689 crore on revenue of ₹5,675 crore. Promoters held 68.69% of the shares on 31 December 2018.
Latest balance sheet
31 March 2026
Shareholding pattern
31 December 2018
Bayer Cropscience at a glance · consolidated
ROE (FY26)
23.7%+3.8 pts vs FY25ROCE 25.3%
Promoter holding
68.69%unchanged vs 30 Sep 201831 December 2018
Net worth
₹2,966 Cr31 March 2026
Free cash flow (FY26)
₹1,039 Cr
Questions
What is the Bayer Cropscience net worth?
Bayer Cropscience's net worth — shareholders' equity in its consolidated balance sheet — was ₹2,966 crore on 31 March 2026.
What is the Bayer Cropscience dividend in 2026 and its record date?
In 2026, Bayer Cropscience has declared one dividend: ₹60 with record date 5 August 2026.
What is the Bayer Cropscience free cash flow?
In FY26, Bayer Cropscience generated ₹1,079 crore of cash from operations and spent ₹39.9 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹1,039 crore.
What is the Bayer Cropscience ROE and ROCE?
In FY26, Bayer Cropscience's return on equity (ROE) was 23.7% and its return on capital employed (ROCE) was 25.3%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 19.9% and ROCE 20.1%.
What is the Bayer Cropscience promoter holding?
Promoters held 68.69% of Bayer Cropscience on 31 December 2018, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.
How does Bayer Cropscience compare with its peers?
On FY26 consolidated figures, against UPL and PI Industries: Bayer Cropscience's operating margin of 13.7% is the second highest of the three (UPL 11.6%, PI Industries 19.3%; peer average 15.4%); its return on equity of 23.7% is the highest of the three (UPL 6.0%, PI Industries 12.2%; peer average 9.1%).
What is the Bayer Cropscience revenue and profit in FY26?
In FY26 (April 2025–March 2026), Bayer Cropscience's consolidated net profit was ₹689 crore, up 21.3% from ₹568 crore in FY25, on revenue from operations of ₹5,675 crore (up 3.7%).
Bayer Cropscience vs UPL: how do they compare?
In FY26, Bayer Cropscience earned net profit of ₹689 crore on revenue of ₹5,675 crore, against ₹1,922 crore on ₹51,839 crore for UPL. Bayer Cropscience's operating margin was 13.7% (UPL 11.6%) and its return on equity 23.7% (UPL 6.0%).
Where do these Bayer Cropscience figures come from?
From Bayer Cropscience's own consolidated results, balance sheets and shareholding patterns filed with NSE. Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.
